These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15285883)

  • 1. Clinical aspects of radiation nephropathy.
    Breitz H
    Cancer Biother Radiopharm; 2004 Jun; 19(3):359-62. PubMed ID: 15285883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of external beam dose-response relationships to kidney toxicity associated with radionuclide therapy.
    O'Donoghue J
    Cancer Biother Radiopharm; 2004 Jun; 19(3):378-87. PubMed ID: 15285886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation nephropathy.
    Cohen EP; Robbins ME
    Semin Nephrol; 2003 Sep; 23(5):486-99. PubMed ID: 13680538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal toxicity after radionuclide therapy.
    Lambert B; Cybulla M; Weiner SM; Van De Wiele C; Ham H; Dierckx RA; Otte A
    Radiat Res; 2004 May; 161(5):607-11. PubMed ID: 15161361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary and perspectives on kidney dose-response to radionuclide therapy.
    Wessels B
    Cancer Biother Radiopharm; 2004 Jun; 19(3):388-90. PubMed ID: 15285887
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
    Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
    J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theoretical radiobiological assessment of the influence of radionuclide half-life on tumor response in targeted radiotherapy when a constant kidney toxicity is maintained.
    Abou-Jaoudé W; Dale R
    Cancer Biother Radiopharm; 2004 Jun; 19(3):308-21. PubMed ID: 15285877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to kidney dose-response for radionuclide therapy.
    Sgouros G
    Cancer Biother Radiopharm; 2004 Jun; 19(3):357-8. PubMed ID: 15285882
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonuniform absorbed dose distribution in the kidney: the influence of organ architecture.
    Green A; Flynn A; Pedley RB; Dearling J; Begent R
    Cancer Biother Radiopharm; 2004 Jun; 19(3):371-7. PubMed ID: 15285885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation nephropathy: a review.
    Robbins ME; Bonsib SM
    Scanning Microsc; 1995 Jun; 9(2):535-60. PubMed ID: 8714748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiation pathology of the kidneys].
    Strel'tsova VN; Shikhodyrov VV; Poluboiarinova ZI
    Arkh Patol; 1968; 30(2):25-33. PubMed ID: 5661639
    [No Abstract]   [Full Text] [Related]  

  • 13. Captopril preserves function and ultrastructure in experimental radiation nephropathy.
    Cohen EP; Molteni A; Hill P; Fish BL; Ward WF; Moulder JE; Carone FA
    Lab Invest; 1996 Sep; 75(3):349-60. PubMed ID: 8804358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation nephropathy in rats and its modification by the angiotensin converting enzyme inhibitor enalapril.
    Yildiz F; Atahan II; Yildiz O
    Radiat Med; 2000; 18(3):153-9. PubMed ID: 10972545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic examination of the influence of dietary protein on rat radiation nephropathy.
    Mahler PA; Oberley TD; Yatvin MB
    Radiat Res; 1982 Mar; 89(3):546-58. PubMed ID: 7063629
    [No Abstract]   [Full Text] [Related]  

  • 16. Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody.
    Breitz HB; Fisher DR; Wessels BW
    J Nucl Med; 1998 Oct; 39(10):1746-51. PubMed ID: 9776281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of indium-111-labeled platelets and indium-111 oxine by murine kidneys after total-body irradiation.
    Ebbe S; Taylor S; Maurer H; Kullgren B
    Radiat Res; 1996 Aug; 146(2):216-22. PubMed ID: 8693071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependence of radiation nephropathy in the rat.
    Moulder JE; Fish BL
    Radiat Res; 1997 Mar; 147(3):349-53. PubMed ID: 9052682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of stem cells in kidney disease.
    Chhabra P; Brayman KL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
    Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
    Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.